D M Lathers - JoVE Visualize

Showing results (1-10 of 11) with videos related to

Pageof 2

Sort By:

International Journal of Immunopharmacology|July 17, 1999

Myeloid progenitor cells mediate immune suppression in patients with head and neck cancersM R Young, D M Lathers

International Journal of Immunopharmacology|March 1, 2003

Skewed differentiation of bone marrow CD34+ cells of tumor bearers from dendritic toward monocytic cells, and the redirection of differentiation toward dendritic cells by 1alpha,25-dihydroxyvitamin D3M R Young, M A Wright, K Vellody, et al.

Journal of Leukocyte Biology|May 20, 1999

Dendritic cell differentiation pathways of CD34+ cells from the peripheral blood of head and neck cancer patientsD M Lathers, E Lubbers, M A Wright, et al.

International Journal of Cancer|July 15, 1999

Increased resistance to apoptosis by bone marrow CD34(+)progenitor cells from tumor-bearing miceM R Young, M A Wright, D M Lathers, et al.

Human Immunology|November 13, 2001

Phase IB study of 25-hydroxyvitamin D(3) treatment to diminish suppressor cells in head and neck cancer patientsD M Lathers, J I Clark, N J Achille, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000

Vitamin D3 treatment to diminish the levels of immune suppressive CD34+ cells increases the effectiveness of adoptive immunotherapyK M Wiers, D M Lathers, M A Wright, et al.

The Annals of Otology, Rhinology, and Laryngology|August 29, 2000

CD34+ immune suppressive cells in the peripheral blood of patients with head and neck cancerR Pandit, D M Lathers, N M Beal, et al.

Human Immunology|January 8, 2000

Cultures derived from peripheral blood CD34+ progenitor cells of head and neck cancer patients and from cord blood are functionally differentD M Lathers, E Lubbers, N M Beal, et al.

Human Immunology|April 11, 2001

Human squamous cell carcinomas of the head and neck chemoattract immune suppressive CD34(+) progenitor cellsM R Young, G J Petruzzelli, K Kolesiak, et al.

Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|September 14, 2001

Increased levels of immune inhibitory CD34+ progenitor cells in the peripheral blood of patients with node positive head and neck squamous cell carcinomas and the ability of these CD34+ cells to differentiate into immune stimulatory dendritic cellsD M Lathers, N Achille, K Kolesiak, et al.

Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:

Pageof 2

International Journal of Immunopharmacology|July 17, 1999

Myeloid progenitor cells mediate immune suppression in patients with head and neck cancersM R Young, D M Lathers

International Journal of Immunopharmacology|March 1, 2003

Skewed differentiation of bone marrow CD34+ cells of tumor bearers from dendritic toward monocytic cells, and the redirection of differentiation toward dendritic cells by 1alpha,25-dihydroxyvitamin D3M R Young, M A Wright, K Vellody, et al.

Journal of Leukocyte Biology|May 20, 1999

Dendritic cell differentiation pathways of CD34+ cells from the peripheral blood of head and neck cancer patientsD M Lathers, E Lubbers, M A Wright, et al.

International Journal of Cancer|July 15, 1999

Increased resistance to apoptosis by bone marrow CD34(+)progenitor cells from tumor-bearing miceM R Young, M A Wright, D M Lathers, et al.

Human Immunology|November 13, 2001

Phase IB study of 25-hydroxyvitamin D(3) treatment to diminish suppressor cells in head and neck cancer patientsD M Lathers, J I Clark, N J Achille, et al.

Journal of Immunotherapy (Hagerstown, Md. : 1997)|February 25, 2000

Vitamin D3 treatment to diminish the levels of immune suppressive CD34+ cells increases the effectiveness of adoptive immunotherapyK M Wiers, D M Lathers, M A Wright, et al.

The Annals of Otology, Rhinology, and Laryngology|August 29, 2000

CD34+ immune suppressive cells in the peripheral blood of patients with head and neck cancerR Pandit, D M Lathers, N M Beal, et al.

Human Immunology|January 8, 2000

Cultures derived from peripheral blood CD34+ progenitor cells of head and neck cancer patients and from cord blood are functionally differentD M Lathers, E Lubbers, N M Beal, et al.

Human Immunology|April 11, 2001

Human squamous cell carcinomas of the head and neck chemoattract immune suppressive CD34(+) progenitor cellsM R Young, G J Petruzzelli, K Kolesiak, et al.

Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|September 14, 2001

Increased levels of immune inhibitory CD34+ progenitor cells in the peripheral blood of patients with node positive head and neck squamous cell carcinomas and the ability of these CD34+ cells to differentiate into immune stimulatory dendritic cellsD M Lathers, N Achille, K Kolesiak, et al.

Pageof 2